AFT Pharmaceuticals Limited (ASX:AFP)

Market Cap	264.79M
Revenue (ttm)	182.21M
Net Income (ttm)	10.65M
Shares Out	n/a
EPS (ttm)	0.09
PE Ratio	24.85
Forward PE	n/a
Dividend	0.01 (0.59%)
Ex-Dividend Date	Jun 19, 2024

Volume	2
Average Volume	1,617
Open	2.490
Previous Close	2.500
Day's Range	2.490 - 2.490
52-Week Range	2.150 - 3.300
Beta	0.36
RSI	40.75
Earnings Date	Feb 20, 2025

About AFT Pharmaceuticals

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, gastrointestinal, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, vitamins, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 110
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AFP

Financial Performance

In 2023, AFT Pharmaceuticals's revenue was 195.41 million, an increase of 24.75% compared to the previous year's 156.64 million. Earnings were 15.61 million, an increase of 46.51%.

Financial numbers in NZD